Nektar Therapeutics
N-methyl-N-(1-phenyl-2-(1-pyrrolidinyl)ethyl)-2-aminophenylacetamide derivatives agonists for the .kappa. opioid receptor

Last updated:

Abstract:

Compounds and pharmaceutically acceptable salts and solvates thereof are described. The compounds relate to and/or have application(s) in (among others) the fields of drug discovery, pharmacotherapy, physiology and organic chemistry.

Status:
Grant
Type:

Utility

Filling date:

14 May 2019

Issue date:

8 Feb 2022